Answers are grounded in this paper and cite their sources.
Objective To investigate the clinical symptoms of pyruvate kinase deficiency (PKD) and the new mutation type of PKLR gene in 3 cases of PKD, and to explore the method for PKD gene diagnosis. Methods Sequencing of blood system-related genes in 3 children was performed by target sequence capture and high-throughput sequencing technology, and the protein function of mutant gene was forecasted, after detecting the pathogenicity of the patients, these genotypes were confirmed by Sanger sequencing. Results In the 3 children, 5 types of PKLR gene mutations were found: double heterozygous mutations c. 1529G>A(p.R510Q)and c. 1031T>G(p.I344S), homozygous mutation c. 847G> T (p.V283F), double heterozygous mutations c. 979delC(p.L327fs)and c. 604_617del(p.V202fs). PKLR gene c. 1529G>A(p.R510Q)mutation had been reported previously, and the other four mutations were new.c.1031T> G (p.I344S) and c. 847G> T (p.V283F) was possibly pathogenic mutation, which meant that the probability of mutation of this gene was more than 90% and c. 979delC (p.L327fs) and c. 604_617del (p.V202fs) variation was a pathogenic variation.These 5 mutations had a greater effect on protein function, and all of them were pathogenic mutations. Conclusion Since PKD patients are difficult to be diagnosed clinically, PKLR gene variation can be detected by target sequence capture and high throughput sequencing technology, and the pathogenicity of the new mutant is evaluated.
No takes yet. Share an insight, caveat, or question.
Cao et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: